Literature DB >> 3106217

Structural requirements of muramylpeptides for induction of necrosis at sites primed with Mycobacterium tuberculosis in guinea pigs.

S Nagao, H Takada, K Yagawa, H Kutsukake, T Shiba, S Kusumoto, S Kawata, A Hasegawa, M Kiso, I Azuma.   

Abstract

Intracutaneous injection of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) in guinea pigs caused an extensive necrotic reaction in footpads prepared by injection of heat-killed Mycobacterium tuberculosis in water-in-mineral-oil emulsion. We examined a variety of analogs and derivatives of muramylpeptides for their ability to provoke this reaction. A maximum and a minimum structure responsible for the necrotic reaction were found to be N-acetylglycosaminyl-beta(1-4)-N-acetylmuramyl-tripeptide (GlcNAc-MurNAc-L-Ala-D-isoGln-meso-A2pm) and MDP, respectively. An unexpected finding was that GlcNAc-MurNAc-tetrapeptides having L-amino acids at their C termini, unlike comparable compounds having C-terminal D-amino acids, exhibited definite necrosis-inducing activity, probably due to their tendency to undergo in vivo degradation to GlcNAc-MurNAc-tripeptide. Introduction of some acyl groups, especially the stearoyl group, to the 6-O position of the muramic acid or the peptide moiety of muramylpeptides increased the necrosis-inducing activity of the parent molecules. However, this was not observed with 1-thio-muramic acid analogs of MDP. Modification of the alpha- or gamma-carboxyl groups of the glutamic acid residues of muramylpeptides tended to decrease their necrosis-inducing ability. Analogs and derivatives of muramylpeptides which are capable of inducing necrosis at a primed site, with few exceptions, exhibited powerful adjuvanticity against ovalbumin in guinea pigs. However, the reverse was not necessarily true.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106217      PMCID: PMC260502          DOI: 10.1128/iai.55.5.1279-1288.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum.

Authors:  S Kotani; Y Watanabe; T Shimono; F Kinoshita; T Narita
Journal:  Biken J       Date:  1975-06

2.  Purification of beta-N-acetylglucosaminidase from the pig epididymis.

Authors:  J FINDLAY; G A LEVVY
Journal:  Biochem J       Date:  1960-10       Impact factor: 3.857

3.  Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.

Authors:  I Azuma; K Sugimura; M Yamawaki; M Uemiya; S Kusumoto; S Okada; T Shiba; Y Yamamura
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

4.  Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; T Shimono; K Harada; T Shiba
Journal:  Biken J       Date:  1976-03

5.  Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide).

Authors:  E E Ribi; J L Cantrell; K B Von Eschen; S M Schwartzman
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

6.  Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.

Authors:  A Tanaka; S Nagao; R Nagao; S Kotani; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

7.  Macrophage stimulation in vitro by an inactive muramyl dipeptide derivative after conjugation to a multi-poly(DL-alanyl)-poly(L-lysine) carrier.

Authors:  A Galelli; Y Le Garrec; L Chedid; P Lefrancier; M Derrien; M Level
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

8.  Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from various gram-positive bacteria.

Authors:  S Kotani; T Narita; D E Stewart-Tull; T Shimono; Y Watanabe
Journal:  Biken J       Date:  1975-06

9.  Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.

Authors:  S Kotani; F Kinoshita; I Morisaki; T Shimono; T Okunaga; H Takada; M Tsujimoto; Y Watanabe; K Kato; T Shiba; S Kusumoto; S Okada
Journal:  Biken J       Date:  1977-12

10.  A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock.

Authors:  Y B Kim; D W Watson
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

View more
  3 in total

1.  Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture.

Authors:  S Yang; R Tamai; S Akashi; O Takeuchi; S Akira; S Sugawara; H Takada
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Macrophages are stimulated by muramyl dipeptide to induce polymorphonuclear leukocyte accumulation in the peritoneal cavities of guinea pigs.

Authors:  S Nagao; M Nakanishi; H Kutsukake; K Yagawa; S Kusumoto; T Shiba; A Tanaka; S Kotani
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Structural characteristics of peptidoglycan fragments required to prime mice for induction of anaphylactoid reactions by lipopolysaccharides.

Authors:  H Takada; Y Kawabata; S Kawata; S Kusumoto
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.